tert-Butyl 3-((2-(5-cyanopyrazin-2-ylamino)-5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)pyridin-4-ylamino)methyl)piperidine-1-carboxylate → 5-(5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)-4-(piperidin-3-ylmethylamino)pyridin-2-ylamino)pyrazine-2-carbonitrile

HRID 556822Notes

Reaction equation

HRID 556822 reaction equation
[C:1]([C:3]1[N:4]=[CH:5][C:6]([NH:9][C:10]2[CH:15]=[C:14]([NH:16][CH2:17][CH:18]3[CH2:23][CH2:22][CH2:21][N:20](C(OC(C)(C)C)=O)[CH2:19]3)[C:13]([N:31]3[CH:35]=[CH:34][C:33]([CH2:36][N:37]4[CH2:42][CH2:41][O:40][CH2:39][CH2:38]4)=[CH:32]3)=[CH:12][N:11]=2)=[N:7][CH:8]=1)#[N:2]>CO>[O:40]1[CH2:41][CH2:42][N:37]([CH2:36][C:33]2[CH:34]=[CH:35][N:31]([C:13]3[C:14]([NH:16][CH2:17][CH:18]4[CH2:23][CH2:22][CH2:21][NH:20][CH2:19]4)=[CH:15][C:10]([NH:9][C:6]4[N:7]=[CH:8][C:3]([C:1]#[N:2])=[N:4][CH:5]=4)=[N:11][CH:12]=3)[CH:32]=2)[CH2:38][CH2:39]1

Participants

3

Procedure

Crude tert-butyl 3-((2-(5-cyanopyrazin-2-ylamino)-5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)pyridin-4-ylamino)methyl)piperidine-1-carboxylate (90 mg) was dissolved in methanol (1 mL) and absorbed onto a TsOH solid phase extraction cartridge and allowed to stand for 2 h. The cartridge was eluted with 7M ammonia in methanol. The basic fractions were evaporated to dryness. The crude product was purified by HPLC to give 5-(5-(3-(morpholinomethyl)-1H-pyrrol-1-yl)-4-(piperidin-3-ylmethylamino)pyridin-2-ylamino)pyrazine-2-carbonitrile (4.93 mg, 7% over 3 steps).

Workup

  1. customabsorbed onto a TsOH solid phase extraction cartridge
  2. washThe cartridge was eluted with 7M ammonia in methanol
  3. customThe basic fractions were evaporated to dryness
  4. customThe crude product was purified by HPLC

Sources & evidence

ORD record
ord-46ac11dc889d4e36b0f0c682d4fd2bf3
Source dataset
uspto-grants-2011_11
Patent number
US08058045B2

Reaction notes

Loading…